DNTH Positive Sentiment
Dianthus Therapeutics to Participate in Upcoming Investor Healthcare Conferences in November
Wednesday, November 1, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Dianthus Therapeutics has announced that its senior management team will participate in several investor healthcare conferences throughout November. These conferences include notable events such as the Guggenheim Securities 5th Annual Inflammation, Neurology & Immunology Conference in New York City and the Jefferies 2023 London Healthcare Conference. The company's participation highlights its commitment to advancing its innovative antibody complement therapeutics and engaging with potential investors.
Full Press Release Details
NEW YORK and WALTHAM, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today announced that the Company’s senior management team will participate in the following upcoming investor healthcare conferences during the month of November:
Guggenheim Securities 5th Annual Inflammation, Neurology & Immunology Conference on November 6 in New York City
Jefferies 2023 London Healthcare Conference on November 14-15 in London
Evercore ISI 6th Annual HealthCONx Conference on November 28-29 in Miami
About Dianthus Therapeutics